Pages that link to "Q37851636"

The following pages link to Progress in understanding adjuvant immunotoxicity mechanisms (Q37851636):

Displaying 48 items.

• Cytokines as biomarkers of nanoparticle immunotoxicity (Q28383550) (← links)
• Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts (Q28387541) (← links)
• Near-infrared laser adjuvant for influenza vaccine (Q28536886) (← links)
• Hydroxypropyl-β-cyclodextrin spikes local inflammation that induces Th2 cell and T follicular helper cell responses to the coadministered antigen. (Q30371719) (← links)
• Influenza Vaccine and Adjuvant (Q30410120) (← links)
• Laser vaccine adjuvants. History, progress, and potential (Q30413501) (← links)
• A coimmunization vaccine of Aβ42 ameliorates cognitive deficits without brain inflammation in an Alzheimer's disease model (Q30581976) (← links)
• Postural Orthostatic Tachycardia With Chronic Fatigue After HPV Vaccination as Part of the "Autoimmune/Auto-inflammatory Syndrome Induced by Adjuvants": Case Report and Literature Review (Q33166316) (← links)
• Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release. (Q33760871) (← links)
• Lumazine synthase protein cage nanoparticles as antigen delivery nanoplatforms for dendritic cell-based vaccine development (Q33850508) (← links)
• Production of inflammatory cytokines in response to diphtheria-pertussis-tetanus (DPT), haemophilus influenzae type b (Hib), and 7-valent pneumococcal (PCV7) vaccines (Q34033774) (← links)
• A pilot study on developing mucosal vaccine against alveolar echinococcosis (AE) using recombinant tetraspanin 3: Vaccine efficacy and immunology. (Q34222728) (← links)
• Silica nanoparticles as the adjuvant for the immunisation of mice using hepatitis B core virus-like particles (Q34600988) (← links)
• Immunogenicity and safety of Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: a randomized controlled Phase 1 study (Q34621859) (← links)
• Resin monomers act as adjuvants in Ni-induced allergic dermatitis in vivo (Q34950458) (← links)
• Immunogenicity of individual vaccine components in a bivalent nicotine vaccine differ according to vaccine formulation and administration conditions (Q35061547) (← links)
• Association between neuromyelitis optica and tuberculosis in a Chinese population (Q35098917) (← links)
• Classification of Laser Vaccine Adjuvants (Q35996738) (← links)
• New proteoliposome vaccine formulation from N. meningitidis serogroup B, without aluminum hydroxide, retains its antimeningococcal protectogenic potential as well as Th-1 adjuvant capacity (Q36639063) (← links)
• Chitin, chitosan, and glycated chitosan regulate immune responses: the novel adjuvants for cancer vaccine (Q36702887) (← links)
• Non-invasive administration of biodegradable nano-carrier vaccines (Q37596856) (← links)
• Induction of innate and adaptive immunity by delivery of poly dA:dT to dendritic cells (Q37626826) (← links)
• Recombinant cytokines from plants. (Q37900138) (← links)
• Micro and nanoparticle-based delivery systems for vaccine immunotherapy: an immunological and materials perspective (Q38066148) (← links)
• Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity (Q38100941) (← links)
• Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines (Q38112504) (← links)
• Role of Fused Mycobacterium tuberculosis Immunogens and Adjuvants in Modern Tuberculosis Vaccines. (Q38209327) (← links)
• The basics and advances of immunomodulators and antigen presentation: a key to development of potent memory response against pathogens (Q38217630) (← links)
• Adjuvants and delivery systems for antifungal vaccines: current state and future developments (Q38264288) (← links)
• The Hen's Egg Test on Chorioallantoic Membrane: An Alternative Assay for the Assessment of the Irritating Effect of Vaccine Adjuvants. (Q39298187) (← links)
• Near-Infrared 1064 nm Laser Modulates Migratory Dendritic Cells To Augment the Immune Response to Intradermal Influenza Vaccine. (Q40134053) (← links)
• Hemozoin is a potent adjuvant for hemagglutinin split vaccine without pyrogenicity in ferrets (Q40210840) (← links)
• A rabies vaccine adjuvanted with saponins from leaves of the soap tree (Quillaja brasiliensis) induces specific immune responses and protects against lethal challenge (Q40824269) (← links)
• Effects of Apium graveolens Extract on the Oxidative Stress in the Liver of Adjuvant-Induced Arthritic Rats (Q42430052) (← links)
• A 4-month-old baby presenting with dermal necrotizing granulomatous giant cell reaction at the injection site of 13-valent pneumococcal conjugate vaccine: a case report (Q42853528) (← links)
• The Future of Autoimmunity (Q43786536) (← links)
• Do aluminum vaccine adjuvants contribute to the rising prevalence of autism? (Q44755590) (← links)
• Toxicity and dose determination of quillaja saponin, aluminum hydroxide and squalene in olive flounder (Paralichthys olivaceus). (Q46204200) (← links)
• Reactogenicity and safety assessment of an attenuated nanovaccine against scorpion envenomation: Preclinical study (Q46863886) (← links)
• Mechanisms of aluminum adjuvant toxicity and autoimmunity in pediatric populations (Q48718127) (← links)
• Letter to the editor - HPV vaccine and autoimmunity Incidence of new-onset autoimmune disease in girls and women with pre-existing autoimmune disease after quadrivalent human papillomavirus vaccination: a cohort study. (Q53814320) (← links)
• Influenza Vaccine and Autoimmune Diseases (Q58051969) (← links)
• Transfer of the ability of HIV-1 Tat to raise an adjuvant-free humoral immune response to unrelated antigens (Q83564526) (← links)
• Vaccine Adjuvants: Is the Pipeline Clogged? (Q84566614) (← links)
• Repeated dose (14 days) rat intramuscular toxicology study of Her1 vaccine (Q85240338) (← links)
• Adjuvants as Delivery Systems in Antigen-Specific Immunotherapies (Q90130184) (← links)
• Better Adjuvants for Better Vaccines: Progress in Adjuvant Delivery Systems, Modifications, and Adjuvant-Antigen Codelivery (Q90398348) (← links)
• Immunization with pneumococcal elongation factor Tu enhances serotype-independent protection against Streptococcus pneumoniae infection (Q93158222) (← links)